enteric

(redirected from enteric-coated)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Wikipedia.

enteric

, enteral
intestinal
References in periodicals archive ?
Inclusion criteria included taking and not taking enteric-coated aspirin for more than 3 months without obvious gastrointestinal symptoms (abdominal pain, abdominal distension, diarrhoea, acid regurgitation, or heartburn), for the aspirin and healthy control groups, respectively.
As the liquid form of aspirin capsules is not yet commercially available, plain aspirin would be preferred over the enteric-coated version.
The primary study endpoint--the incidence of endoscopically confirmed gastroduodenal ulcers--occurred in 2.0% of patients on PA32540, compared with 12.4% of controls on enteric-coated aspirin.
With repeated exposure, individuals categorized as nonresponders when given enteric-coated aspirin showed evidence of responses when administered immediate-release aspirin.
Both ER minocycline and delayed-release, enteric-coated doxycycline (Doryx) feature once-a-day dosing that should improve compliance, said Dr.
Practice Implications: This new clinical trial again demonstrates the safety and efficacy of enteric-coated peppermint oil for the relief of symptoms associated with IBS.
Some people with irritable bowel syndrome that results in chronic, dull pain and bowel spasms find relief with an enteric-coated peppermint/caraway oil preparation called Regimint[TM].
concluded an agreement on January 29 for the co-development and co-marketing of Asacol - development code Z-206, generic name mesalazine, Asacol is an oral enteric-coated pharmaceutical formulation of mesalazine, a drug for inflammatory bowel disease (IBD).
It is said that enteric-coated niacin is not quite as effective.
The recommendation regarding timing of the ibuprofen dose does not apply to patients taking enteric-coated low-dose aspirin, as such an advisement cannot be made based on the data available.
Novartis Pharma AG, Basel, Switzerland, announced that its application for its new enteric-coated immunosuppressive drug, Myfortic (mycophenolate sodium) successfully completed the European Mutual Recognition Procedure (MRP) in 17 countries.
Enteric-coated Slow-Mag tablets are slow-release and generally well tolerated.